Analysis of GzmbCre as a Model System for Gene Deletion in the Natural Killer Cell Lineage

Yiying Xu; Cesar Evaristo; Maria-Luisa Alegre; Sandeep Gurbuxani; Barbara L. Kee

doi:10.1371/journal.pone.0125211

Abstract

The analysis of gene function in mature and activated natural killer cells has been hampered by the lack of model systems for Cre-mediated recombination in these cells. Here we have investigated the utility of Gzmb^Cre for recombination of loxp sequences in these cells predicated on the observation that Gzmb mRNA is highly expressed in mature and activated natural killer cells. Using two different reporter strains we determined that gene function could be investigated in mature natural killer cells after Gzmb^Cre mediated recombination in vitro in conditions that lead to natural killer cell activation such as in the cytokine combination of interleukin 2 and interleukin 12. We demonstrated the utility of this model by creating Gzmb^Cre;Rosa26^IKKbca mice in which Cre-mediated recombination resulted in expression of constitutively active IKKβ, which results in activation of the NFκB transcription factor. In vivo and in vitro activation of IKKβ in natural killer cells revealed that constitutive activation of this pathway leads to natural killer cell hyper-activation and altered morphology. As a caveat to the use of Gzmb^Cre we found that this transgene can lead to recombination in all hematopoietic cells the extent of which varies with the particular loxp flanked allele under investigation. We conclude that Gzmb^Cre can be used under some conditions to investigate gene function in mature and activated natural killer cells.

Citation: Xu Y, Evaristo C, Alegre M-L, Gurbuxani S, Kee BL (2015) Analysis of Gzmb^Cre as a Model System for Gene Deletion in the Natural Killer Cell Lineage. PLoS ONE 10(4): e0125211. https://doi.org/10.1371/journal.pone.0125211

Academic Editor: Jose Alberola-Ila, Oklahoma Medical Research Foundation, UNITED STATES

Received: August 31, 2014; Accepted: March 23, 2015; Published: April 29, 2015

Copyright: © 2015 Xu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Data Availability: All data are within the paper.

Funding: This work was funded by the National Institute of Allergy and Infectious Diseases (R01 AI106352 to B. L. K.) and a training grant from the National Institute of Diabetes and Digestive and Diseases (T32 DK007074 to Y. X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Natural killer (NK) cells are lymphocytes that function at the intersection of innate and adaptive immunity and they are promising targets for cancer immunotherapy [1]. They recognize virus-infected, stressed, or cancerous cells through multiple germ line encoded activating and inhibitory receptors [2]. When an imbalance in these signaling inputs occurs that favors activating over inhibitory receptor signaling, NK cells rapidly produce inflammatory cytokines including interferon (IFN) γ and tumor necrosis factor (TNF) α and undergo degranulation releasing perforin and granzymes to kill associated target cells [3]. NK cells can also be activated by dendritic cell (DC) derived inflammatory cytokines such as interleukin (IL)12 and IL18 and they can alter DC function through numerous mechanisms thereby augmenting or limiting the adaptive immune response [4]. NK cells are considered a component of the innate immune system due to their basal primed effector state, which allows for rapid responses prior to engagement of the adaptive immune response. However, recent studies have revealed that NK cells, like adaptive immune cells, can display characteristics of memory cells including a heightened response to secondary challenge and antigen specificity [5,6,7].

Our understanding of the molecular mechanisms controlling NK cell function is limited, particularly when compared to our understanding of adaptive immune system cells. One reason for this under-appreciation is that model systems in which genes can be specifically deleted from, or expressed in, NK cells are not widely available. Indeed, until recently, the only way to test gene function in mature (m) NK cells was through targeted disruption of a gene in the germ line or in all hematopoietic cells using Cre recombinase expressing transgenes that delete in hematopoietic stem cells such as Vav^Cre or Tie2^Cre [8,9]. These models have the obvious caveat that genes that are required for development of the multipotent progenitors of early NK lineage cells cannot be tested in mNK cells. For example, the functions of the nuclear factor (NF) κB family have been investigated in NK cells using germ line deletion of two inhibitors of this transcription factor, IκBα and IκBε whose deletion results in constitutive activity of NFκB. In Iκbα^-/-;Iκbε^-/- mice, NK cell development arrests at the immature (i) NK cell stage suggesting that constitutive activation of NFκB is lethal at a stage prior to the development of mNK cells [10]. In contrast, human patients with an inactivating mutation in the IKKγg/NEMO kinase, which functions in a complex that promotes NFκB activation by phosphoryating IκB proteins and targeting them for ubiquitination and degradation, develop mNK cells that show limited cytotoxic function [11]. It remains unclear whether this reduced cytotoxic capacity is due to requirements for NFκB in mNK cells or during earlier stages of NK cell development, where a lack of functional NFκB may have impaired acquisition of cytolytic competence. Consequently, the significance of NFκB activation in mNK cells has not been directly evaluated.

Recently, mouse strains were described that produce Cre under the control of the Ncr1 promoter [12] or the entire Ncr1 locus [13], which encodes for the activating NK cell receptor NKp46 [14,15]. In these mice, Cre-mediated recombination initiates during the iNK cell stage, prior to the generation of mNK cells but downstream of the most immature NK cell progenitors (NKP) [16]. Ncr1 is expressed primarily in NK cells but is also expressed in subsets of T cells and innate lymphoid cells, requiring that both populations be considered in phenotype interpretation of mice in which a gene is deleted using Ncr1^Cre [13]. While the Ncr1^Cre strains are highly useful for investigating gene function in NK cells, the field could benefit from additional Cre-producing strains that delete at later stages of NK cell development or after NK cell activation.

Here we report that the Gzmb^Cre transgenic mouse can be used to delete genes in activated mNK cells. Gzmb^Cre has been used extensively for studies of effector and memory CD8 T cells because it promotes Cre-mediated recombination in CD8 T cells at the height of the effector response [17]. We found that Cre mRNA was expressed at a low level throughout the hematopoietic system of Gzmb^Cre mice and that Cre-mediated recombination could detected in many cell types. Nonetheless, activated mNK cells from Gzmb^Cre mice strongly upregulated Cre mRNA and efficiently recombined loxp-flanked sequences. We propose that Gzmb^Cre can be used for loxp-dependent deletion or activation of genes in activated mNK cells in vitro or after transplantation in vivo, after which NK cell function can be assessed using multiple assays. We demonstrated the utility of Gzmb^Cre by crossing this allele into Rosa26^IKKbca mice, which produce a constitutively active form of the IKKβ protein (IKKβ-CA) after Cre-mediated recombination. The Gzmb^Cre;Rosa26^IKKbca genotype allowed us to investigate the consequences of NFκB activation in mNK cells and revealed that constitutive activation of IKKβ led to hyperactivation and morphological alterations.

Methods and Materials

Mice

This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee of the University of Chicago (Assurance # A3523-01) under the Animal Care and Use Protocol # 71116. Animals were sacrificed using CO₂ asphyxiation followed by cervical disclocation. The Rosa26^IKKbca (C57BL/6- Gt(Rosa)26Sor^{tm1(Ikbkb)/Rsky/}J) [18], Rosa26^EYFP (B6.129X1- Gt(Rosa)26Sor^{tm1(EYFP)Cos/}J) [19] and Rosa26^{ACTB-tdTomato, -EGFP} (C57BL/6-Gt(Rosa)26Sor^{tm4(ACTB-tdTomato, -EGFP)Luo/}J) mice [20] were purchased from Jackson Laboratories. Gzmb^Cre mice on a C57Bl/6 background were provided by Dr. E. John Wherry and have been described previously [17].

Flow Cytometry

Cells were stained with fluorochrome- or biotin-labeled antibodies for 30 min on ice. The following antibodies conjugated to FITC, PE, PerCp-Cy5.5, PerCP-ef710, PeCy7, APC, APC-ef780, Pacific Blue, or Brilliant Violet 421 were purchased from eBiosciences or BD Biosciences: CD3ε, CD4, CD8α, CD19, Ter119, CD122, NK1.1, NKp46, DX5, CD69, CD11b, CD25, Klrg1, IL7Rα, Sca1, cKit, CD43, B220, and Gr1. Propidium iodide was used to exclude dead cells. Cells were acquired on a FACS Canto, LSRII, or Fortessa or sorted with a FACS ARIAII and analyzed with FLOWjo. Through this study mNK cells were identified using a lineage cocktail containing CD19, CD3, CD4, CD8, and Ter119 antibodies and propidium iodide to exclude dead cells. NK cells were either Lin-CD122+NK1.1⁺ or Lin-CD122+NKp46/NK1.1+ and DX5⁺. NKP were defined as Lin-CD122⁺NK1.1^-.

NK cell cultures and activation

Primary mNK cells were isolated from the spleen of mice on a FACSAria and culture in vitro in conditions that were approved by the Institutional Biosafety Committee at the University of Chicago. The NK cells were cultured in Opti-MEM supplemented with 10% FBS, 80μM 2-mercaptoethanol, 100U/ml penicillin, 100μg/ml streptomycin, and 29.2mg/ml glutamine, IL2 (1000 IU/ml, NIH AIDS Reagents program) with or without IL12 (3.3ng/ml, Peprotech). In vivo, NK cells were activated by an intraperitoneal injection of 150μg (150 μl of a 1 mg/ml solution) of poly(I:C) and evaluated 72 hrs post injection by flow cytometry.

QPCR

RNA was purified from FACS sorted cells using the RNAeasy micro kit (QIAGEN) and reverse-transcribed with Superscript III (Invitrogen). QPCR was performed with gene-specific primers in an iCycler (BioRad) using the iQ SYBR Green Supermix (BioRad) as recommended by the manufacture. Hprt, amplified in the same RNA sample, was used to normalize gene expression. Hprt-66F, 5′-ACCTCTCGAAGTGTTGGATA-3′; Hprt-66R, 5′-CAA CAA CAA ACT TGT CTG GA-3′; Cre for, 5’- CGT ACT GAC GGT GGG AGA AT-3’; Cre rev 5’-CCC GGC AAA ACA GGT AGT TA-3’; Gzmb for 5’-ACA GAA GGA TCG GGA GTG TG -3’; Gzmb rev 5’-CTA TGC CTG CAG CCA CTT TT -3’

Statistical Analysis

Standard t-tests were used to determine statistical significance using the GraphPad software program.

Results and Discussion

Variegated expression of YFP in mNK cells from Gzmb^Cre;Rosa26^EYFP mice

Gzmb mRNA is expressed in mNK cells and increases upon NK cell activation leading us to hypothesize that Gzmb^Cre might be useful for recombination of loxp-flanked sequences in these cells. To test this hypothesis we crossed Gzmb^Cre mice, which produce Cre under the control of a fragment of the human Gzmb promoter [17], to multiple reporter mouse strains. We examined Gzmb^Cre;Rosa26^EYFP mice, in which the Rosa26 locus expresses enhanced yellow fluorescent protein (YFP) only after Cre-mediated recombination and deletion of a loxp-flanked STOP translation sequence that is upstream of the YFP coding sequence [19]. Flow cytometry analysis revealed that only a portion of the Lin^-CD122⁺NKp46⁺DX5⁺ mNK cells from the bone marrow of these mice expressed YFP (Fig 1A and 1B). The frequency of YFP positive cells in any given mouse was similar among mNK cells isolated from the bone marrow, spleen, liver or lymph node (Fig 1B). The frequency of YFP⁺ mNK cells varied between 3 and 20% in the bone marrow of mice as old as 12 weeks of age but there was no significant difference in the frequency of YFP⁺ cells in any of the tissues examined (Fig 1D). Therefore, at least a subset of mNK cells or their precursors expressed Cre from the Gzmb^Cre allele.

Download:

Fig 1. Gzmb^Cre;Rosa26^EYFP mice have a low frequency of YFP⁺ mNK cells.

(A) Representative FACS histograms showing the gating strategy for mNK cells in Gzmb^Cre;Rosa26^EYFP mice. Lymphoid cells were gated by FSC and SSC (left panel) and then Lineage/PI negative cells that express CD122 (center plot) were selected and examined for expression of NKp46 and DX5. In some experiments mNK cells were Lineage/PI negative CD122⁺NK1.1⁺ as shown in Fig 3A. (B) The frequency of mNK cells expressing EYFP in a typical Gzmb^Cre;Rosa26^EYFP mouse bone marrow (BM), spleen (spl), lymph node (LN) and liver. (C) Scatter plots showing frequency of YFP⁺ mNK cells in the bone marrow of multiple Gzmb^Cre;Rosa26^EYFP mice at different ages. Each circle represents one mouse. (D) The average number of YFP⁺ mNK cells is shown for each of the indicated tissues in mice between 6 and 12 weeks of age. Error bars = standard deviation. n > 5 for each tissue. The difference in average YFP⁺ mNK cell number between different tissues was not statistically significant.

https://doi.org/10.1371/journal.pone.0125211.g001

Activation-dependent recombination of Rosa26^EYFP by Gzmb^Cre

We hypothesize that Gzmb^Cre may be more highly expressed in activated mNK cells than in resting mNK cells because Gzmb mRNA increases with NK cell activation. To test this hypothesis we isolated YFP negative mNK cells from Gzmb^Cre;Rosa26^EYFP mice by cell sorting and cultured these cells in vitro in IL2 alone or IL2 + IL12 (Fig 2A and 2B). Mature NK cells cultured in IL2 proliferate and become primed but they are not fully activated [21]. A small fraction of IL2-stimulated YFP negative NK cells began to express YFP with approximately 6% of NK cells being YFP⁺ by day 9 of culture (Fig 2B and 2C). In contrast to IL2 alone, IL2 + IL12 results in NK cell activation including degranulation and production of IFNγ [21]. When cultured in IL2 + IL12 a greater frequency of mNK cells began to express YFP, reaching frequencies > 55% between 6 and 9 days after activation (Fig 2B and 2C). Our data demonstrated that Gzmb^Cre recombines loxp-flanked sequences in a subset of mNK cells and that recombination could be augmented in vitro under conditions of activation.

Download:

Fig 2. In vitro activation promotes Cre-mediated recombination in Gzmb^Cre;Rosa26^EYFP mNK cells.

(A) YFP^- mNK cells were isolated from the spleen of Gzmb^Cre;Rosa26^EYFP mice by flow cytometric sorting and they were cultured in (B) IL2 alone (upper panels) or IL2 + IL12 (lower panels) for 3, 6 or 9 days prior to analysis by flow cytometry for YFP expression. (C) The average frequency of YFP⁺ mNK cells on day 3, 6, and 9 after in vitro culture in IL2 (black) or IL2 + IL12 (grey). Error bars = standard deviation. n>5, ** p < 0.01.

https://doi.org/10.1371/journal.pone.0125211.g002

Reporter variation in Gzmb^Cre-mediated recombination

It has been noted previously that reporter alleles can differ in their sensitivity to recombination by Cre and reporter assays have been developed to exploit engineered differences [22,23,24,25,26]. Therefore, we assessed the ability of Gzmb^Cre to promote recombination of a second reporter construct. We chose the Rosa26^{ACTB-tdTomato, -EGFP} reporter, which produces a transmembrane form of tomato red fluorescent protein (RFP) constitutively under the control of the actin promoter, which is inserted into the Rosa26 locus [20]. Cre-mediated recombination deletes the tomato red coding sequence and brings the sequence for enhanced green fluorescent protein (GFP) under the control of the actin promoter. In Gzmb^Cre;Rosa26^{ACTB-tdTomato, -EGFP/+} mice we again observed that only a subset of mNK cells in the bone marrow, spleen, lymph node and liver expressed the GFP reporter (Fig 3A and 3B), and this frequency was highly variable in mice between 6 and 12 weeks of age (Fig 3C). The frequency of GFP⁺ cells was similar in different tissues from the same mouse. On average, a higher frequency of mNK cells from Gzmb^Cre;Rosa26^{ACTB-tdTomato, -EGFP/+} mice showed evidence of Cre activity compared to those in Gzmb^Cre;Rosa26^EYFP mice (Figs 3D and 1D, p<0.01 for all tissues).

Download:

Fig 3. Gzmb^Cre;Rosa26^{ACTB-tdTomato, -EGFP/+} mice have a low frequency of GFP⁺ mature NK cells.

(A) Representative FACS histograms showing the gating strategy for mNK cells in Gzmb^Cre;Rosa26^{ACTB-tdTomato, -EGFP/+} mice. Lymphoid cells were gated by FSC and SSC (left panel) and then Lineage negative, PI- cells (center plot) were selected and examined for expression of NK1.1 and CD122. (B) The frequency of mNK cells expressing GFP in a typical Gzmb^Cre;Rosa26^{ACTB-tdTomato, -EGFP/+} mouse bone marrow (BM), spleen, lymph node (LN) and liver. The frequency of GFP⁺ cells is indicated. (C) Scatter plots showing the frequency of YFP⁺ mNK cells in the bone marrow of multiple Gzmb^Cre;Rosa26^{ACTB-tdTomato, -EGFP/+} mice at different ages. Each circle represents one mouse. (D) The average number of GFP⁺ mNK cells is shown for each of the indicated tissues in mice between 6 and 12 weeks of age. Error bars = standard deviation. n > 7 for each tissue. The difference in average GFP⁺ mNK cell number between different tissues was not statistically significant.

https://doi.org/10.1371/journal.pone.0125211.g003

We next tested the ability of Gzmb^Cre to recombine the Rosa26^{ACTB-tdTomato, -EGFP} reporter in vitro. When GFP^- mNK cells were cultured in IL2 alone, a low frequency of cells began to express GFP within 6 days (Fig 4A–4C). In contrast, greater than 60% of GFP^- mNK cells became GFP⁺ within 3 days after initiation of culture in IL2 + IL12 (Fig 4B). On average, close to 80% of mNK cells were GFP⁺ by day 6 of culture in IL2 + IL12 (Fig 4C). To activate NK cells in vivo we injected Gzmb^Cre;Rosa26^{ACTB-tdTomato, -EGFP/+} mice with 150 ug poly(I:C) i.v. and compared the number of GFP⁺ mNK cells to those in mice injected with a comparable volume of PBS. However, we were not able to reliably determine whether poly(I:C) treatment increased the frequency of GFP⁺ cells because of the variability we observed in the frequency of GFP⁺ mNK cells between individual animals. Nonetheless, poly(I:C) treatment did result in an increased frequency of eGFP⁺ mNK cells in the liver as compared to the bone marrow of individual mice (Fig 3D and 3E). This enrichment of GFP⁺ cells in the liver was not observed in PBS treated Gzmb^Cre;Rosa26^{ACTB-tdTomato, -EGFP/+} mice (Fig 3D and 3E). Therefore, we conclude that Gzmb^Cre recombines loxp-flanked sequences in activated mNK cells, which are then enriched in the liver.

Download:

Fig 4. In vitro activation causes Cre-mediated recombination in Gzmb^Cre;Rosa26^{ACTB-tdTomato, -EGFP/+} mature NK cells.

(A) GFP^- mNK cells were isolated from the spleen of Gzmb^Cre;Rosa26^{ACTB-tdTomato, -EGFP/+} mice by flow cytometric sorting and cultured in (B) IL2 alone (upper panels) or IL2 + IL12 (lower panels) for 3 or 6 days prior to analysis by flow cytometry for GFP expression. (C) The average frequency of GFP⁺ mNK cells on day 6 of culture for cells grown in IL2 or IL2 + IL12 is shown. n = 5, *** = p<0.001. (D) Mice were injected i.p. with 150 ug of poly(I:C) or PBS as control, and analyzed 3 days later. GFP⁺ cells in the bone marrow (black) and liver (grey) are shown from a representative PBS (left plot) or poly(I:C) (right plot) injected mouse. (E) The average number of GFP⁺ mNK cells in the bone marrow and liver of poly(I:C) treated mice is indicated. Error bars = standard error. n = 4, ** = p< 0.01.

https://doi.org/10.1371/journal.pone.0125211.g004

Gzmb^Cre is expressed broadly in the hematopoietic system

To determine whether the Gzmb^Cre-mediated recombination observed in mNK cells in vivo was specific to mNK cells, we examined GFP expression in NK cell progenitors (NKP) using the Rosa26^{ACTB-tdTomato, -EGFP} reporter. To our surprise, we found that GFP was expressed in these cells, albeit the average percentage of GFP⁺ cells was slightly lower than in the mNK cells from the same mouse (Fig 5A and 5B). This surprising observation indicated that Cre expression did not faithfully mimic endogenous Gzmb mRNA expression and prompted us to look more broadly among hematopoietic cells for Gzmb^Cre-directed recombination events. Remarkably, we found that CD19⁺ B cells, DN3 thymocytes, CD4⁺ thymocytes and CD11b⁺ macrophages all showed evidence of Gzmb^Cre-mediated recombination in this reporter strain (Fig 5C). Most notably, expression of GFP was also observed in multipotent hematopoietic progenitors including the Lin^-SCA1⁺cKIT⁺ (LSK) population that contains hematopoietic stem cells (Fig 5C). An analysis Cre mRNA revealed that there was a low level of expression in LSKs and CLPs (Fig 5D). By contrast, Gzmb mRNA was not detected in LSKs or CLPs (Fig 5D). Notably, and in contrast to Gzmb mRNA, Cre mRNA did not increase in mNK cells compared to LSKs, explaining the low level of recombination in mNK cells (Fig 5D). However, in vitro activation of mNK cells resulted in a robust (>10-fold) induction of both Gzmb and Cre mRNA (Fig 5D). Our data demonstrate that Gzmb^Cre had the potential to recombine loxp sequences in hematopoietic progenitors resulting in recombined alleles in many hematopoietic lineages. Nonetheless, recombination was increased specifically in activated mNK cells indicating that under some conditions Gzmb^Cre can be used to investigate gene function in activated mNK cells.

Download:

Fig 5. Detection of Gzmb^Cre-mediated recombination in multiple hematopoietic cell types.

(A) Representative FACS plot showing GFP expression in bone marrow Lin/PI^-CD122⁺NK1.1^- NKP (grey) and Lin/PI^-CD122⁺NK1.1⁺ mNK cells (black) from an 8 week old Gzmb^Cre;Rosa26^{ACTB-tdTomato, -EGFP/+} mouse. The shaded histogram is the isotype control. (B) The average number of GFP⁺ NKP and mNK cells from mice between 8 and 12 weeks of age. n = 5, * = p< 0.05 (C) eGFP expression in LSKs (Lin-SCA1⁺cKIT⁺), CD19⁺ bone marrow cells, DN3 cells, CD4⁺ thymocytes and CD11b⁺ bone marrow cells from mice at 12 weeks of age. One of three representative experiments is shown. (D) QPCR analysis of Cre (black) and Gzmb (grey) mRNA from LSKs, CLPs (Lin^-CD127⁺cKIT⁺SCA1⁺Flt3⁺), NKPs, and mNK cells or from primary splenic NK cells or splenic NK cells cultured in IL2 or IL2 + IL12 for 6 days. mRNA expression was normalized to Hprt using the ΔCT method. n = 3, ** = p< 0.01, *** = p< 0.001.

https://doi.org/10.1371/journal.pone.0125211.g005

Constitutive activation of IKKβ in mNK cells resulted in an activated phenotype

To further investigate the utility of Gzmb^Cre for studies of gene function in mNK cells we examined Gzmb^Cre-mediated recombination of the Rosa26^IKKbca transgene. This transgene encodes a constitutively active (CA) form of IKKβ, a kinase that phosphorylates IκB proteins leading to their ubiquitin-mediated degradation and consequently the activation of NFκB, knocked in to the Rosa26 locus [18]. NFκB is activated in response to ligation of multiple activating NK cell receptors and inflammatory cytokines [27,28], and is proposed to be necessary for NK cell cytotoxicity [29]. Indeed, an inactivating mutation in IKKγ was found in multiple patients that had defective NK cell-mediated cytotoxic responses [11]. While NFκB is active at a low level in most NK cells, deregulation of its function through germ line mutation of IκBα and IκBε results a decline in mature NK cell numbers, arrested maturation and a failure to produce IFNγ [10]. Therefore, we tested whether constitutive activation of IKKβ, and consequently activation of NFκB, would lead to alterations in mNK cells. Notably, in vivo at steady state there were few GFP⁺ NK cells in the bone marrow, spleen, lymph nodes and liver of Gzmb^Cre;Rosa26^IKKbca transgenic mice (Fig 6A). However, there were consistently more GFP⁺ cells in the liver than in the other tissues (Fig 6A). In contrast, Gzmb^Cre;Rosa26^{ACTB-tdTomato, -EGFP/+} mice did not show a difference in GFP expression between bone marrow and liver mNK cells unless the mice were treated with poly(I:C) to activate the NK cells (Fig 4D). Therefore, the enrichment of GFP⁺ cells in the liver of Gzmb^Cre;Rosa26^IKKbca transgenic mice at steady state is consistent with the hypothesis that the IKKβ-CA protein resulted in activation of the NK cells. In accordance with this hypothesis, the GFP⁺ cells in the liver of these mice were more granular than their GFP^- counterparts and they were enriched for expression of CD69 and KLRG1 (Fig 6B and 6C), which are markers of NK cell activation [30]. In contrast to the Gzmb^Cre;Rosa26^{ACTB-tdTomato, -EGFP/+} mice, we did not detect GFP expression among CD19+ B lymphocytes or DN3 thymocytes (data not show). Injection of Gzmb^Cre;Rosa26^IKKbca transgenic mice with poly(I:C) lead to a consistent but not significant increase in the number of GFP⁺ cells (Fig 6B). Therefore, mNK cells with constitutively active IKKβ can be detected in vivo and these cells show evidence of activation.

Download:

Fig 6. Constitutive IKKβ activation in mNK cells leads to characteristics of activation.

(A) Bar graphs show the average frequency of GFP⁺ mNK cells in the bone marrow, spleen, lymph node and liver of Gzmb^Cre;Rosa26^IKKbca mice between 8 and 12 weeks of age. Error bars = standard error. n = 4, ** p<0.01. (B) Gzmb^Cre;Rosa26^IKKbca mice were injected with PBS or poly(I:C) (150 ug) and analyzed 72 hrs later by flow cytometry for expression of GFP and CD69 on mNK cells in the indicated tissues. Gzmb^Cre mice injected with PBS were analyzed as a negative control for GFP. (C) Flow cytometric analysis of SSC, CD69 and KLRG1 from GFP⁺ (shaded histogram) and GFP^- (open histograms) Gzmb^Cre;Rosa26^IKKbca liver NK cells.

https://doi.org/10.1371/journal.pone.0125211.g006

To gain further insight into the consequences of IKKβ activation in mNK cells, we examined mNK cells after in vitro recombination of the Rosa26^IKKbca transgene. As we observed with the Rosa26 reporter alleles, in vitro culture of GFP^- Gzmb^Cre;Rosa26^IKKbca mNK cells in IL2 promoted weak recombination of the Gzmb^Cre;Rosa26^IKKbca allele (Fig 7A). However, a substantial frequency of GFP^- Gzmb^Cre;Rosa26^IKKbca mNK cells became GFP⁺ after a 5 day culture in IL2 + IL12 (Fig 7A). IL2 + IL12 causes NK cell activation, however, the IKKβ-CA expressing mNK cells cultured under these conditions were even larger and more granular than their GFP^- counterparts (Fig 7B), indicating that these cells were hyperactivated. Indeed, the IKKβ-CA expressing cells also had very high surface expression of the activation markers CD25, CD69, and KLRG1 (Fig 7C). When transferred from IL2 + IL12 to IL2 alone, to allow the cells to return to conditions that are not activating, the GFP⁺ cells became irregular in appearance and adherent to the plastic dish making quantification difficult. On Giemsa stained preparations, the GFP⁺ cells were larger and showed large coarse granules when compared to the GFP^- cells (Fig 7D and 7E). These data led us to conclude that constitutive activation of IKKβ resulted in NK cell hyperactivation as measured by increased size and granularity and the high level of expression of activation markers, changes in adhesive properties, and altered morphologic characteristics. Therefore, while activation of NFκB is necessary for NK cell function, constitutive activation of NFκB could lead to chronic activation as well as functional and morphologic changes that could prevent their accumulation.

Download:

Fig 7. Constitutive IKKβ activation leads to NK cell hyper-activation and altered morphology.

(A) GFP^- mNK cells from the spleen of Gzmb^Cre;Rosa26^IKKbca mice were isolated by cell sorting and cultured in IL2 or IL2 + IL12 for 5 days prior to analysis of GFP expression by flow cytometry. One representative experiment of 3 is shown. (B) FSC and SSC analysis of the GFP⁺ (black) and GFP^- (grey) cells from the day 5 IL2 + IL12 cultures. (C) Expression of CD25, CD69, and KLRG1 on the GFP⁺ (black) and GFP^- (grey) cells from the day 5 IL2 + IL12 cultures. The shaded grey histogram represents the isotype control staining for GFP⁺ cells. (D) Giemsa stain for GFP^- and (E) GFP⁺ cells 5 days after transfer of cells from IL2 + IL12 cultures to IL2 alone. One of 3 similar experiments is shown; 100 pixels = 10 μm, 400X.

https://doi.org/10.1371/journal.pone.0125211.g007

Discussion

The Gzmb^Cre mouse model has been used for studies of gene function in activated or memory CD8 T cells [17,31]. Since Gzmb is also expressed in NK cells we investigated the utility of this model for gene deletion in mNK cells. We found that Gzmb^Cre can be used to investigate gene function in activated mNK cells, particularly in vitro. However, this Cre-deleter strain showed considerable variability with respect to the extent of deletion in mNK cells and in other hematopoietic cell types including hematopoietic stem cells and multipotent progenitors. On the low end of the spectrum a few percent of mNK cells and other cell types showed evidence of Cre-mediated recombination. In contrast, one of the reporters we utilized showed that greater than 50% of most hematopoietic cells had undergone recombination. These studies reveal the potential heterogeneity in detecting Cre-mediated recombination by different reporter alleles revealing that these reporters may not faithfully recapitulate recombination frequencies at an allele of interest. Moreover, our study also indicated that gene deletion with Gzmb^Cre can be heterogeneous and can initiate as early as the hematopoietic stem cell in some strains of mice. Despite these caveats we were able to demonstrate the utility of this model for Cre mediated recombination in mNK cells in vitro and in vivo.

While our study raises some caveats with respect to the utility of Gzmb^Cre, we found that it could be used to investigate the function of genes that are directly linked to a reporter gene such as GFP. As an example, we examined the consequences of expressing constitutively active IKKβ in mNK cells. IKKβ is one of the two kinase subunits of the IKK complex, which phosphorylates the IκB proteins that hold multiple NFκB subunits in an inactive state in the cytoplasm [32]. Constitutive activation of IKKβ results in phosphorylation of IκB proteins resulting in their targeted degradation by the ubiquitin-proteasome system and nuclear translocation of NFκB transcription factors. We found that IKKβ-CA⁺ cells induced by Gzmb^Cre could be detected at a low frequency in the absence of intentional NK cell activation and were more frequently found in the liver as compared to the bone marrow, spleen and lymph nodes. Therefore, constitutive activation of NFκB may influence the migration or tissue retention patterns of NK cells. IKKβ-CA mNK cells were more granular than their IKKβ-CA negative counterparts and showed higher expression of CD69, a marker associated with NK cell activation [33]. In vitro, the cytokine combination of IL2 + IL12 induced a subset of mNK cells to express the IKKβ-CA transgene and these cells could be maintained in vitro in IL2. Interestingly, IKKβ-CA⁺ mNK cells that survived for extended times in vitro showed a morphological change becoming extremely large and having an extensive granular network with large vacuoles. This phenotype was not observed when GFP^- cells were analyzed from the same starting sample or when YFP⁺ cells from Gzmb^Cre;Rosa26^EYFP mice were tracked in vitro (data not shown). Therefore, constitutive express of IKKβ-CA results in hyperactivation of mNK cells and morphological changes. In vivo, the Rosa26^IKKbca transgene could be expressed in other hematopoietic cells that might influence the fate of NK cells. However, the hyperactivation of mNK cells expressing IKKβ-CA appears to be an intrinsic consequence of IKKβ-CA expression in NK cells because it was observed in in vitro cultures of purified mNK cells that underwent Cre mediated recombination after the initiation of culture. Taken together, our results demonstrate that the Gzmb^Cre transgenic mouse can be used for studies of gene function in activated mNK cells.

Acknowledgments

We are grateful to members of the Kee laboratory for helpful discussions. This work was supported by a grant from the NIH R01 AI106352 to B.L.K. Y.X. was supported the Training Grant in Digestive Diseases and Nutrition (T32 DK007074).

Author Contributions

Conceived and designed the experiments: YX BLK. Performed the experiments: YX SG CE. Analyzed the data: YX CE SG BLK. Contributed reagents/materials/analysis tools: MLA. Wrote the paper: BLK.

References

1. Campbell KS, Hasegawa J (2013) Natural killer cell biology: an update and future directions. J Allergy Clin Immunol 132: 536–544. pmid:23906377
- View Article
- PubMed/NCBI
- Google Scholar
2. Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23: 225–274. pmid:15771571
- View Article
- PubMed/NCBI
- Google Scholar
3. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331: 44–49. pmid:21212348
- View Article
- PubMed/NCBI
- Google Scholar
4. Marcais A, Viel S, Grau M, Henry T, Marvel J, Walzer T (2013) Regulation of mouse NK cell development and function by cytokines. Frontiers in Immunology 4: 450. pmid:24376448
- View Article
- PubMed/NCBI
- Google Scholar
5. Min-Oo G, Kamimura Y, Hendricks DW, Nabekura T, Lanier LL (2013) Natural killer cells: walking three paths down memory lane. Trends Immunol 34: 251–258. pmid:23499559
- View Article
- PubMed/NCBI
- Google Scholar
6. Cooper MA, Yokoyama WM (2010) Memory-like responses of natural killer cells. Immunol Rev 235: 297–305. pmid:20536571
- View Article
- PubMed/NCBI
- Google Scholar
7. Sun JC, Ugolini S, Vivier E (2914) Immunological memory within the innate immune system. EMBO J 33: 1295–1303.
- View Article
- Google Scholar
8. Georgiades P, Ogilvy S, Duval H, Licence DR, Charnock-Jones DS, Smith SK, et al. (2002) VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages. Genesis 34: 251–256. pmid:12434335
- View Article
- PubMed/NCBI
- Google Scholar
9. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M (2001) Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol 230: 230–242. pmid:11161575
- View Article
- PubMed/NCBI
- Google Scholar
10. Samson SI, Memet S, Vosshenrich CA, Colucci F, Richard O, Ndiaye D, et al. (2004) Combined deficiency in IkappaBalpha and IkappaBepsilon reveals a critical window of NF-kappaB activity in natural killer cell differentiation. Blood 103: 4573–4580. pmid:14764534
- View Article
- PubMed/NCBI
- Google Scholar
11. Orange JS, Brodeur SR, Jain A, Bonilla FA, Schneider LC, Kretschmer R, et al. (2002) Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest 109: 1501–1509. pmid:12045264
- View Article
- PubMed/NCBI
- Google Scholar
12. Eckelhart E, Warsch W, Zebedin E, Simma O, Stoiber D, Kolbe T, et al. (2010) A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Blood 117: 1565–1573. pmid:21127177
- View Article
- PubMed/NCBI
- Google Scholar
13. Narni-Mancinelli E, Chaix J, Fenis A, Kerdiles YM, Yessaad N, Reynders A, et al. (2011) Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc Natl Acad Sci U S A 108: 18324–18329. pmid:22021440
- View Article
- PubMed/NCBI
- Google Scholar
14. Biassoni R, Pessino A, Bottino C, Pende D, Moretta L, Moretta A (1999) The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur J Immunol 29: 1014–1020. pmid:10092106
- View Article
- PubMed/NCBI
- Google Scholar
15. Pessino A, Sivori S, Bottino C, Malaspina A, Morelli L, Moretta L, et al. (1998) Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med 188: 953–960. pmid:9730896
- View Article
- PubMed/NCBI
- Google Scholar
16. Rosmaraki EE, Douagi I, Roth C, Colucci F, Cumano A, Di Santo JP (2001) Identification of committed NK cell progenitors in adult murine bone marrow. Eur J Immunol 31: 1900–1909. pmid:11433387
- View Article
- PubMed/NCBI
- Google Scholar
17. Jacob J, Baltimore D (1999) Modelling T-cell memory by genetic marking of memory T cells in vivo. Nature 399: 593–597. pmid:10376601
- View Article
- PubMed/NCBI
- Google Scholar
18. Sasaki Y, Derudder E, Hobeika E, Pelanda R, Reth M, Rajewsky K, et al. (2006) Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24: 729–739. pmid:16782029
- View Article
- PubMed/NCBI
- Google Scholar
19. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM, et al. (2001) Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1: 4. pmid:11299042
- View Article
- PubMed/NCBI
- Google Scholar
20. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L (2007) A global double-fluorescent Cre reporter mouse. Genesis 45: 593–605. pmid:17868096
- View Article
- PubMed/NCBI
- Google Scholar
21. Brady J, Carotta S, Thong RP, Chan CJ, Hayakawa Y, Smyth MJ, et al. (2010) The interactions of multiple cytokines control NK cell maturation. J Immunol 185: 6679–6688. pmid:20974986
- View Article
- PubMed/NCBI
- Google Scholar
22. Heffner CS, Herbert Pratt C, Babiuk RP, Sharma Y, Rockwood SF, Donahue LR, et al. (2012) Supporting conditional mouse mutagenesis with a comprehensive cre characterization resource. Nat Commun 3: 1218. pmid:23169059
- View Article
- PubMed/NCBI
- Google Scholar
23. Lewis AE, Vasudevan HN, O'Neill AK, Soriano P, Bush JO (2013) The widely used Wnt1-Cre transgene causes developmental phenotypes by ectopic activation of Wnt signaling. Dev Biol 379: 229–234. pmid:23648512
- View Article
- PubMed/NCBI
- Google Scholar
24. Matthaei KI (2007) Genetically manipulated mice: a powerful tool with unsuspected caveats. J Physiol 582: 481–488. pmid:17495035
- View Article
- PubMed/NCBI
- Google Scholar
25. Sun MY, Yetman MJ, Lee TC, Chen Y, Jankowsky JL (2014) Specificity and efficiency of reporter expression in adult neural progenitors vary substantially among nestin-CreER(T2) lines. J Comp Neurol 522: 1191–1208. pmid:24519019
- View Article
- PubMed/NCBI
- Google Scholar
26. Klinger M, Chmura SA, Killeen N (2010) Reporter alleles that inform on differences in Cre recombinase expression. J Immunol 184: 6170–6176. pmid:20427774
- View Article
- PubMed/NCBI
- Google Scholar
27. Pandey R, DeStephan CM, Madge LA, May MJ, Orange JS (2007) NKp30 ligation induces rapid activation of the canonical NF-kappaB pathway in NK cells. J Immunol 179: 7385–7396. pmid:18025182
- View Article
- PubMed/NCBI
- Google Scholar
28. Rajasekaran K, Kumar P, Schuldt KM, Peterson EJ, Vanhaesebroeck B, Dixit V, et al. (2013) Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells. Nat Immunol 14: 1127–1136. pmid:24036998
- View Article
- PubMed/NCBI
- Google Scholar
29. Orange JS (2013) Natural killer cell deficiency. J Allergy Clin Immunol 132: 515–525. pmid:23993353
- View Article
- PubMed/NCBI
- Google Scholar
30. Huntington ND, Tabarias H, Fairfax K, Brady J, Hayakawa Y, Degli-Esposti MA, et al. (2007) NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol 178: 4764–4770. pmid:17404256
- View Article
- PubMed/NCBI
- Google Scholar
31. Hand TW, Cui W, Jung YW, Sefik E, Joshi NS, Chandele A, et al. (2010) Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. Proc Natl Acad Sci U S A 107: 16601–16606. pmid:20823247
- View Article
- PubMed/NCBI
- Google Scholar
32. Hoffmann A, Baltimore D (2006) Circuitry of nuclear factor kappaB signaling. Immunol Rev 210: 171–186. pmid:16623771
- View Article
- PubMed/NCBI
- Google Scholar
33. Lanier LL, Buck DW, Rhodes L, Ding A, Evans E, Barney C, et al. (1988) Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med 167: 1572–1585. pmid:3259252
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Campbell KS, Hasegawa J (2013) Natural killer cell biology: an update and future directions. J Allergy Clin Immunol 132: 536–544. pmid:23906377
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23: 225–274. pmid:15771571
View Article
PubMed/NCBI
Google Scholar

[6] View Article

[7] PubMed/NCBI

[8] Google Scholar

[ref3] 3. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331: 44–49. pmid:21212348
View Article
PubMed/NCBI
Google Scholar

[10] View Article

[11] PubMed/NCBI

[12] Google Scholar

[ref4] 4. Marcais A, Viel S, Grau M, Henry T, Marvel J, Walzer T (2013) Regulation of mouse NK cell development and function by cytokines. Frontiers in Immunology 4: 450. pmid:24376448
View Article
PubMed/NCBI
Google Scholar

[14] View Article

[15] PubMed/NCBI

[16] Google Scholar

[ref5] 5. Min-Oo G, Kamimura Y, Hendricks DW, Nabekura T, Lanier LL (2013) Natural killer cells: walking three paths down memory lane. Trends Immunol 34: 251–258. pmid:23499559
View Article
PubMed/NCBI
Google Scholar

[18] View Article

[19] PubMed/NCBI

[20] Google Scholar

[ref6] 6. Cooper MA, Yokoyama WM (2010) Memory-like responses of natural killer cells. Immunol Rev 235: 297–305. pmid:20536571
View Article
PubMed/NCBI
Google Scholar

[22] View Article

[23] PubMed/NCBI

[24] Google Scholar

[ref7] 7. Sun JC, Ugolini S, Vivier E (2914) Immunological memory within the innate immune system. EMBO J 33: 1295–1303.
View Article
Google Scholar

[26] View Article

[27] Google Scholar

[ref8] 8. Georgiades P, Ogilvy S, Duval H, Licence DR, Charnock-Jones DS, Smith SK, et al. (2002) VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages. Genesis 34: 251–256. pmid:12434335
View Article
PubMed/NCBI
Google Scholar

[29] View Article

[30] PubMed/NCBI

[31] Google Scholar

[ref9] 9. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M (2001) Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol 230: 230–242. pmid:11161575
View Article
PubMed/NCBI
Google Scholar

[33] View Article

[34] PubMed/NCBI

[35] Google Scholar

[ref10] 10. Samson SI, Memet S, Vosshenrich CA, Colucci F, Richard O, Ndiaye D, et al. (2004) Combined deficiency in IkappaBalpha and IkappaBepsilon reveals a critical window of NF-kappaB activity in natural killer cell differentiation. Blood 103: 4573–4580. pmid:14764534
View Article
PubMed/NCBI
Google Scholar

[37] View Article

[38] PubMed/NCBI

[39] Google Scholar

[ref11] 11. Orange JS, Brodeur SR, Jain A, Bonilla FA, Schneider LC, Kretschmer R, et al. (2002) Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest 109: 1501–1509. pmid:12045264
View Article
PubMed/NCBI
Google Scholar

[41] View Article

[42] PubMed/NCBI

[43] Google Scholar

[ref12] 12. Eckelhart E, Warsch W, Zebedin E, Simma O, Stoiber D, Kolbe T, et al. (2010) A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Blood 117: 1565–1573. pmid:21127177
View Article
PubMed/NCBI
Google Scholar

[45] View Article

[46] PubMed/NCBI

[47] Google Scholar

[ref13] 13. Narni-Mancinelli E, Chaix J, Fenis A, Kerdiles YM, Yessaad N, Reynders A, et al. (2011) Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc Natl Acad Sci U S A 108: 18324–18329. pmid:22021440
View Article
PubMed/NCBI
Google Scholar

[49] View Article

[50] PubMed/NCBI

[51] Google Scholar

[ref14] 14. Biassoni R, Pessino A, Bottino C, Pende D, Moretta L, Moretta A (1999) The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur J Immunol 29: 1014–1020. pmid:10092106
View Article
PubMed/NCBI
Google Scholar

[53] View Article

[54] PubMed/NCBI

[55] Google Scholar

[ref15] 15. Pessino A, Sivori S, Bottino C, Malaspina A, Morelli L, Moretta L, et al. (1998) Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med 188: 953–960. pmid:9730896
View Article
PubMed/NCBI
Google Scholar

[57] View Article

[58] PubMed/NCBI

[59] Google Scholar

[ref16] 16. Rosmaraki EE, Douagi I, Roth C, Colucci F, Cumano A, Di Santo JP (2001) Identification of committed NK cell progenitors in adult murine bone marrow. Eur J Immunol 31: 1900–1909. pmid:11433387
View Article
PubMed/NCBI
Google Scholar

[61] View Article

[62] PubMed/NCBI

[63] Google Scholar

[ref17] 17. Jacob J, Baltimore D (1999) Modelling T-cell memory by genetic marking of memory T cells in vivo. Nature 399: 593–597. pmid:10376601
View Article
PubMed/NCBI
Google Scholar

[65] View Article

[66] PubMed/NCBI

[67] Google Scholar

[ref18] 18. Sasaki Y, Derudder E, Hobeika E, Pelanda R, Reth M, Rajewsky K, et al. (2006) Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24: 729–739. pmid:16782029
View Article
PubMed/NCBI
Google Scholar

[69] View Article

[70] PubMed/NCBI

[71] Google Scholar

[ref19] 19. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM, et al. (2001) Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1: 4. pmid:11299042
View Article
PubMed/NCBI
Google Scholar

[73] View Article

[74] PubMed/NCBI

[75] Google Scholar

[ref20] 20. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L (2007) A global double-fluorescent Cre reporter mouse. Genesis 45: 593–605. pmid:17868096
View Article
PubMed/NCBI
Google Scholar

[77] View Article

[78] PubMed/NCBI

[79] Google Scholar

[ref21] 21. Brady J, Carotta S, Thong RP, Chan CJ, Hayakawa Y, Smyth MJ, et al. (2010) The interactions of multiple cytokines control NK cell maturation. J Immunol 185: 6679–6688. pmid:20974986
View Article
PubMed/NCBI
Google Scholar

[81] View Article

[82] PubMed/NCBI

[83] Google Scholar

[ref22] 22. Heffner CS, Herbert Pratt C, Babiuk RP, Sharma Y, Rockwood SF, Donahue LR, et al. (2012) Supporting conditional mouse mutagenesis with a comprehensive cre characterization resource. Nat Commun 3: 1218. pmid:23169059
View Article
PubMed/NCBI
Google Scholar

[85] View Article

[86] PubMed/NCBI

[87] Google Scholar

[ref23] 23. Lewis AE, Vasudevan HN, O'Neill AK, Soriano P, Bush JO (2013) The widely used Wnt1-Cre transgene causes developmental phenotypes by ectopic activation of Wnt signaling. Dev Biol 379: 229–234. pmid:23648512
View Article
PubMed/NCBI
Google Scholar

[89] View Article

[90] PubMed/NCBI

[91] Google Scholar

[ref24] 24. Matthaei KI (2007) Genetically manipulated mice: a powerful tool with unsuspected caveats. J Physiol 582: 481–488. pmid:17495035
View Article
PubMed/NCBI
Google Scholar

[93] View Article

[94] PubMed/NCBI

[95] Google Scholar

[ref25] 25. Sun MY, Yetman MJ, Lee TC, Chen Y, Jankowsky JL (2014) Specificity and efficiency of reporter expression in adult neural progenitors vary substantially among nestin-CreER(T2) lines. J Comp Neurol 522: 1191–1208. pmid:24519019
View Article
PubMed/NCBI
Google Scholar

[97] View Article

[98] PubMed/NCBI

[99] Google Scholar

[ref26] 26. Klinger M, Chmura SA, Killeen N (2010) Reporter alleles that inform on differences in Cre recombinase expression. J Immunol 184: 6170–6176. pmid:20427774
View Article
PubMed/NCBI
Google Scholar

[101] View Article

[102] PubMed/NCBI

[103] Google Scholar

[ref27] 27. Pandey R, DeStephan CM, Madge LA, May MJ, Orange JS (2007) NKp30 ligation induces rapid activation of the canonical NF-kappaB pathway in NK cells. J Immunol 179: 7385–7396. pmid:18025182
View Article
PubMed/NCBI
Google Scholar

[105] View Article

[106] PubMed/NCBI

[107] Google Scholar

[ref28] 28. Rajasekaran K, Kumar P, Schuldt KM, Peterson EJ, Vanhaesebroeck B, Dixit V, et al. (2013) Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells. Nat Immunol 14: 1127–1136. pmid:24036998
View Article
PubMed/NCBI
Google Scholar

[109] View Article

[110] PubMed/NCBI

[111] Google Scholar

[ref29] 29. Orange JS (2013) Natural killer cell deficiency. J Allergy Clin Immunol 132: 515–525. pmid:23993353
View Article
PubMed/NCBI
Google Scholar

[113] View Article

[114] PubMed/NCBI

[115] Google Scholar

[ref30] 30. Huntington ND, Tabarias H, Fairfax K, Brady J, Hayakawa Y, Degli-Esposti MA, et al. (2007) NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol 178: 4764–4770. pmid:17404256
View Article
PubMed/NCBI
Google Scholar

[117] View Article

[118] PubMed/NCBI

[119] Google Scholar

[ref31] 31. Hand TW, Cui W, Jung YW, Sefik E, Joshi NS, Chandele A, et al. (2010) Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. Proc Natl Acad Sci U S A 107: 16601–16606. pmid:20823247
View Article
PubMed/NCBI
Google Scholar

[121] View Article

[122] PubMed/NCBI

[123] Google Scholar

[ref32] 32. Hoffmann A, Baltimore D (2006) Circuitry of nuclear factor kappaB signaling. Immunol Rev 210: 171–186. pmid:16623771
View Article
PubMed/NCBI
Google Scholar

[125] View Article

[126] PubMed/NCBI

[127] Google Scholar

[ref33] 33. Lanier LL, Buck DW, Rhodes L, Ding A, Evans E, Barney C, et al. (1988) Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med 167: 1572–1585. pmid:3259252
View Article
PubMed/NCBI
Google Scholar

[129] View Article

[130] PubMed/NCBI

[131] Google Scholar

Analysis of Gzmb^Cre as a Model System for Gene Deletion in the Natural Killer Cell Lineage

Analysis of Gzmb^Cre as a Model System for Gene Deletion in the Natural Killer Cell Lineage

Figures

Abstract

Introduction

Methods and Materials

Mice

Flow Cytometry

NK cell cultures and activation

QPCR

Statistical Analysis

Results and Discussion

Variegated expression of YFP in mNK cells from Gzmb^Cre;Rosa26^EYFP mice

Activation-dependent recombination of Rosa26^EYFP by Gzmb^Cre

Reporter variation in Gzmb^Cre-mediated recombination

Gzmb^Cre is expressed broadly in the hematopoietic system

Constitutive activation of IKKβ in mNK cells resulted in an activated phenotype

Discussion

Acknowledgments

Author Contributions

References

Figures

Abstract

Introduction

Methods and Materials

Mice

Flow Cytometry

NK cell cultures and activation

QPCR

Statistical Analysis

Results and Discussion

Variegated expression of YFP in mNK cells from GzmbCre;Rosa26EYFP mice

Activation-dependent recombination of Rosa26EYFP by GzmbCre

Reporter variation in GzmbCre-mediated recombination

GzmbCre is expressed broadly in the hematopoietic system

Constitutive activation of IKKβ in mNK cells resulted in an activated phenotype

Discussion

Acknowledgments

Author Contributions

References

Variegated expression of YFP in mNK cells from Gzmb^Cre;Rosa26^EYFP mice

Activation-dependent recombination of Rosa26^EYFP by Gzmb^Cre

Reporter variation in Gzmb^Cre-mediated recombination

Gzmb^Cre is expressed broadly in the hematopoietic system